Globe Life (NYSE:GL) CFO Thomas Peter Kalmbach Sells 25,650 Shares

29 Jul 2026, 23:08 by Sarita Garza · The Markets Daily

Globe Life Inc. (NYSE:GL – Get Free Report) CFO Thomas Peter Kalmbach sold 25,650 shares of Globe Life stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $178.58, for a total transaction of $4,580,577.00. Following the sale, the chief financial officer owned 50,568 shares in the company, valued at $9,030,433.44. This represents a 33.65% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Thomas Peter Kalmbach also recently made the following trade(s):

On Friday, May 22nd, Thomas Peter Kalmbach sold 7,936 shares of Globe Life stock. The shares were sold at an average price of $156.59, for a total transaction of $1,242,698.24.
On Tuesday, May 19th, Thomas Peter Kalmbach sold 11,903 shares of Globe Life stock. The stock was sold at an average price of $156.61, for a total value of $1,864,128.83.
On Friday, May 8th, Thomas Peter Kalmbach sold 11,790 shares of Globe Life stock. The stock was sold at an average price of $152.02, for a total value of $1,792,315.80.
On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The stock was sold at an average price of $153.65, for a total value of $2,402,625.05.

Globe Life Stock Performance

Shares of Globe Life stock traded up $0.52 on Wednesday, hitting $179.69. The stock had a trading volume of 919,871 shares, compared to its average volume of 565,315. Globe Life Inc. has a 52-week low of $127.85 and a 52-week high of $191.55. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The stock has a market cap of $13.95 billion, a price-to-earnings ratio of 11.93 and a beta of 0.47. The company’s 50 day moving average price is $169.98 and its 200 day moving average price is $153.52.

Globe Life (NYSE:GL – Get Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). The firm had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The company’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, research analysts anticipate that Globe Life Inc. will post 15.73 EPS for the current year.

Globe Life Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be given a dividend of $0.33 per share. The ex-dividend date is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.7%. Globe Life’s dividend payout ratio (DPR) is 8.76%.

Institutional Trading of Globe Life

Hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of Globe Life by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock worth $1,411,311,000 after acquiring an additional 86,349 shares during the period. Invesco Ltd. lifted its position in Globe Life by 2.7% in the fourth quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock valued at $552,262,000 after purchasing an additional 102,445 shares during the period. Dimensional Fund Advisors LP lifted its position in Globe Life by 10.2% in the first quarter. Dimensional Fund Advisors LP now owns 2,353,192 shares of the company’s stock valued at $327,479,000 after purchasing an additional 217,331 shares during the period. Morgan Stanley boosted its holdings in Globe Life by 7.2% in the 4th quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock valued at $260,176,000 after purchasing an additional 125,567 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in Globe Life by 32.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company’s stock valued at $200,734,000 after purchasing an additional 355,399 shares in the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Analyst Ratings Changes

GL has been the subject of several research reports. Weiss Ratings downgraded shares of Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. Keefe, Bruyette & Woods dropped their price objective on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a research note on Friday, July 24th. TD Cowen upped their target price on shares of Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a report on Wednesday, July 22nd. Morgan Stanley raised their price target on Globe Life from $181.00 to $208.00 and gave the stock an “overweight” rating in a report on Monday, July 6th. Finally, JPMorgan Chase & Co. boosted their price target on Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a research report on Tuesday, July 21st. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and a consensus target price of $187.40.

Read Our Latest Stock Analysis on GL

Globe Life Company Profile

(Get Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.